Welcome to our dedicated page for Ryerson Holding SEC filings (Ticker: RYI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Ryerson Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Ryerson Holding's regulatory disclosures and financial reporting.
Key takeaway: On 23 June 2025, Ryerson Holding Corporation (ticker RYI) filed a Form 4 disclosing routine equity accruals for its Chief Accounting Officer & Corporate Controller, Molly D. Kannan.
Transaction details
- Date of transaction: 18 June 2025
- Securities involved: Restricted Stock Units (RSUs) stemming from dividend-equivalent rights. These rights automatically accumulate additional RSUs whenever Ryerson pays a cash dividend on the common stock underlying previously granted, unvested RSUs.
- RSUs credited: 18.601, 36.384 and 60.190 units, respectively – a combined 115.175 shares.
- Cost basis: $0 per unit; the accrual occurs under the original award terms rather than an open-market purchase.
- Total derivative holdings post-transaction: 2,058.206; 4,026.001; and 6,660.190 RSUs across the three grant vintages.
Vesting schedule
- 2023 grant & related dividend equivalents vest in full on 31 Mar 2026.
- 2024 grant vest in two tranches on 31 Mar 2026 and 31 Mar 2027.
- 2025 grant vest in three tranches on 31 Mar 2026, 2027 and 2028.
Investor relevance This filing reflects non-market, routine compensation accruals tied to previously disclosed long-term incentive plans. It neither changes insider ownership meaningfully nor signals a directional view on Ryerson’s valuation. No cash changed hands, and the aggregate 115 additional RSUs represent an immaterial fraction of Ryerson’s ~34 million outstanding shares. Consequently, the filing is best viewed as standard administrative disclosure rather than a catalyst for the stock.